Atlas Trials

Daratumumab to Treat Active Lupus Nephritis

Clinical trial NCT04868838 · ACTIVE_NOT_RECRUITING

Trial details

NCT number
NCT04868838
Sponsor
Mayo Clinic
Status
ACTIVE_NOT_RECRUITING
Phase
Phase 2
Study type
INTERVENTIONAL
Lupus Nephritis
Start date
2021-04-20
Primary completion
2026-09-01
Enrollment
12

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.